While ovarian cancer cells with wild-type p53 have a significant anti-proliferative effect upon PCI-34051 treatment, ovarian cancer cells harboring mutant p53 show minimal anti-proliferative effects. The gene discussed is TP53; the disease is ovarian carcinoma.